Anti-rubella IgG serum levels predict risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infections
Allergy
.
2024 Nov;79(11):3154-3156.
doi: 10.1111/all.16232.
Epub 2024 Jul 9.
Authors
Moritz M Hollstein
1
,
Sascha Dierks
2
3
,
Michael P Schön
1
4
,
Uwe Groß
3
5
,
Karin Thiele
2
3
,
Andreas Leha
6
,
Andreas E Zautner
5
7
8
,
Andreas Fischer
2
3
,
Luise Erpenbeck
1
9
,
Moritz Schnelle
2
3
Affiliations
1
Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
2
Department of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.
3
Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany.
4
Lower Saxony Institute of Occupational Dermatology, University Medical Center Göttingen, Göttingen, Germany.
5
Institute of Medical Microbiology and Virology, University Medical Center Göttingen, Göttingen, Germany.
6
Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
7
Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
8
Center for Health and Medical Prevention (CHaMP), Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
9
Department of Dermatology, University of Münster, Münster, Germany.
PMID:
38979807
DOI:
10.1111/all.16232
No abstract available
Publication types
Letter
Grants and funding
ER723/3-1/German Research Foundation Deutsche Forschungsgemeinschaft
TRR332/German Research Foundation Deutsche Forschungsgemeinschaft